Dustin Drath Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 500 Russell Dr W, Holmen, WI 54636 Phone: 920-538-2148 |
Paula Jo Hueners, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: W7136 Heram Rd, Holmen, WI 54636 Phone: 608-526-9784 |
Mary J Ewers, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 106 South Holmen Dr, Suite 2, Achieve Solutions, Inc., Holmen, WI 54636 Phone: 608-526-9888 |
Michelle Rae Krug, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 106 S Holmen Dr Ste 2, Holmen, WI 54636 Phone: 608-526-9888 |
Home Safety Innovations L.l.c. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 500 Russell Dr W, Holmen, WI 54636 Phone: 920-379-4439 |
Kim Stockheimer, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1604 Viking Ave, Holmen, WI 54636 Phone: 608-526-3042 |
Kimberly Jean Servais, OTR Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 106 S Holmen Dr, Suite 2, Holmen, WI 54636 Phone: 608-989-2195 |
Lee Lohrentz Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 500 Russell Dr W, Holmen, WI 54636 Phone: 920-379-4439 |
Brandon Mccauley, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 106 S Holmen Dr, Suite 2, Holmen, WI 54636 Phone: 608-526-9965 |
Katherine R Parrish, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 106 S Holmen Dr, Suite 2, Holmen, WI 54636 Phone: 608-526-9888 |
News Archive
When researchers examined information on pairs of kidneys from the same donor in which 1 kidney was used but the other was discarded, the kidneys that were used tended to perform well even though they were similar in quality to their partner kidneys that were not used.
Labopharm Inc. today announced that it received notice from the Listings Qualifications Department of The Nasdaq Stock Market (Nasdaq) that the closing bid price of the Corporation's Market Value of Listed Securities (MVLS) was below the minimum requirement of US$50,000,000 for 30 consecutive business days (ended March 28, 2011) and the Corporation was therefore not in compliance with Nasdaq listing rules.
Gilead Sciences, Inc. today announced new data from the open-label phase of two pivotal Phase III clinical trials (Studies 102 and 103) evaluating the four-year efficacy of Viread (tenofovir disoproxil fumarate) for the treatment of chronic hepatitis B virus (HBV) infection.
A new study suggests certain types of consumer behaviors, including flossing with Oral-B Glide dental floss, contribute to elevated levels in the body of toxic PFAS chemicals. PFAS are water- and grease-proof substances that have been linked with numerous health problems.
› Verified 3 days ago